Stellar Health Splits Tech Leadership to Deepen AI Push in Healthcare

NEW YORK, NY – May 28, 2026 – Stellar Health, a technology company working to simplify value-based care, today announced a significant strategic restructuring of its technology leadership. The company has appointed healthcare technology veteran Falko Buttler as its new Chief Technology Officer. In a concurrent move, Co-Founder Octavian Costache will transition from the CTO role to become the company's first Chief Data Officer.

This dual leadership maneuver signals an aggressive push by the well-funded company to accelerate its AI and data-forward platform investments. The move aims to solidify its position in the competitive healthcare technology landscape by dedicating executive focus to both its core engineering infrastructure and its increasingly crucial data and AI strategies.

A Dual Leadership for a New Tech Era

The decision to create separate CTO and CDO roles reflects a growing trend among mature technology companies that view data not just as a byproduct of their operations, but as a core strategic asset. By separating the roles, Stellar Health is assigning distinct, yet complementary, responsibilities at the highest level.

As the new Chief Technology Officer, Buttler will be responsible for the company's core platform, engineering organization, and the technical execution of its product roadmap. His focus will be on building and scaling a robust, reliable, and efficient technology infrastructure. This allows Co-Founder Octavian Costache, in his new role as Chief Data Officer, to concentrate exclusively on Stellar’s “AI-first, data engineering transformation.”

This structure is designed to enable faster, more focused innovation. While Buttler ensures the engine of the platform runs smoothly and scales effectively, Costache will be responsible for refining the fuel—the data—and building the intelligence layer that will define the company’s future. This strategic split acknowledges that succeeding in the next generation of healthcare technology requires excellence in both foundational engineering and sophisticated data science.

“Bringing Falko on board lets us go deeper on the things that will define Stellar's next chapter: our AI roadmap, data architecture, and the engineering foundation we need to scale,” said Octavian Costache. “The work ahead is some of the most important we have done as a company.”

The Proven Scaler: Falko Buttler's Next Chapter

Falko Buttler joins Stellar Health with over two decades of experience leading and scaling engineering teams at high-growth healthcare technology companies. His track record demonstrates a consistent ability to navigate the complex challenges of rapid expansion and post-acquisition integration.

Most recently, as CTO at Lantern, a specialty care network, Buttler led a 100-plus person engineering organization, successfully transitioning the team from a primarily offshore model to a high-caliber local force while the company sustained 40% year-over-year growth. Before that, he was a pivotal member of the leadership team at virtual care provider PlushCare, where he helped scale revenue from $4 million to $125 million, culminating in a successful acquisition by Accolade. As SVP of Engineering at Accolade, he then led the complex technical integration of the two platforms.

This experience is precisely what Stellar Health appears to be seeking as it looks to expand its reach. Michael Meng, CEO & Co-Founder of Stellar Health, noted Buttler’s expertise, stating, “Falko has built and scaled engineering organizations that ship product at the pace this moment demands. He joins us at exactly the right time to turn Stellar's infrastructure position into a durable platform advantage.”

For his part, Buttler expressed a clear-eyed view of the industry’s challenges and Stellar’s unique position.

“I've spent 20 years watching healthcare technology promise transformation and deliver complexity,” said Buttler. “Stellar is different because it already has what everyone else is trying to build: the data, the network, and the financial leverage to actually change behavior. My job is to make that power feel simple — even delightful — in the hands of the people using it.”

Beyond Micro-Incentives: The AI-Activated Platform

Stellar Health has carved out a significant niche in the value-based care market with its unique micro-incentive platform. The platform integrates into existing clinical workflows, providing real-time prompts and financial rewards to providers and their staff for completing specific actions that improve patient outcomes and close care gaps. This model directly addresses provider burnout and administrative friction by making “the right action obvious, immediate, and rewarding.”

The company’s network has grown rapidly to include over 20,000 providers across 2,200 medical practices, impacting more than 1.2 million patients. The new leadership structure is designed to evolve this successful model. The focus will now shift toward creating “intelligent workflows” powered by AI.

This means moving beyond simple checklists to proactively identifying opportunities and automating tasks. For the providers in Stellar’s network, this could translate to AI-driven tools that automate appointment scheduling for follow-up care, facilitate referrals to high-value specialists based on performance data, and dramatically reduce the documentation burden that currently consumes a large portion of a clinician's day.

Investor Confidence and Market Ambition

The strategic hires are backed by significant investor confidence. Stellar Health has raised a total of $156 million from prominent investors including General Atlantic, which led its $60 million Series B round, as well as Point72 Ventures and Primary Venture Partners. These investment firms have built their thesis around companies that can effectively enable the healthcare industry's massive shift from fee-for-service to value-based models.

General Atlantic, in particular, has highlighted its focus on “value-based care enablement,” viewing Stellar’s platform as an intuitive and behavior-focused tool to drive better outcomes. The leadership changes align perfectly with this investor thesis, demonstrating a commitment to leveraging cutting-edge technology to solve core market problems.

By doubling down on both its engineering foundation with Buttler and its AI future with Costache, Stellar Health is signaling its ambition to not just participate in the value-based care ecosystem, but to define its next era. With Buttler and Costache aligned on an integrated platform, data, and AI roadmap, the company enters its next phase of growth with the technical leadership to match its ambitions.